| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Revenue | — | — | — | — | — | — | — | — |
| Cost of Revenue | — | — | — | — | — | — | — | — |
| Gross Profit | — | — | — | — | — | — | — | — |
| R&D Expense | — | — | — | — | — | — | — | — |
| SG&A Expense | — | — | — | — | — | — | — | — |
| Operating Income | — | — | — | — | — | — | — | — |
| Net Income | $0.2B | $0.1B | $0.1B | $0.1B | $0.1B | $0.1B | $0.1B | $0.0B |
| EPS (Basic) | $10.06 | $8.24 | $4.17 | $6.78 | $5.65 | $5.82 | $5.71 | $4.26 |
| EPS (Diluted) | $9.78 | $8.05 | $4.08 | $6.56 | $5.44 | $5.70 | $5.52 | $4.12 |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $9.2B | $8.8B | $8.5B | $8.8B | $7.7B | $4.6B | $3.6B | $3.1B |
| Current Assets | — | — | — | — | — | — | — | — |
| Cash & Equivalents | — | — | — | — | — | — | — | — |
| Total Liabilities | $7.9B | $7.6B | $7.4B | $7.8B | $6.8B | $4.0B | $3.1B | $2.7B |
| Current Liabilities | — | — | — | — | — | — | — | — |
| Stockholders' Equity | $1.3B | $1.2B | $1.0B | $1.0B | $0.9B | $0.5B | $0.5B | $0.4B |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $0.2B | $0.1B | $0.1B | $0.1B | $0.1B | $0.1B | $0.1B | $0.1B |
| Investing Cash Flow | $-0.2B | $-0.3B | $0.6B | $-0.5B | $-0.4B | $-0.2B | $-0.1B | $-0.1B |
| Capital Expenditures | $0.0B | — | — | — | — | — | — | — |
| Financing Cash Flow | $0.2B | $0.2B | $-0.4B | $-0.0B | $0.1B | $0.8B | $-0.1B | $0.1B |